Bruker Corp (NASDAQ: BRKR) has a price-to-earnings ratio that is above its average at 27.15x. The stock has a 36-month beta value of 1.22. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 2 as “overweight,” 10 as “hold,” and 1 as “sell.”
The public float for BRKR is 89.28M, and at present, short sellers hold a 3.70% of that float. On May 02, 2024, the average trading volume of BRKR was 854.69K shares.
BRKR) stock’s latest price update
Bruker Corp (NASDAQ: BRKR)’s stock price has gone rise by 1.31 in comparison to its previous close of 78.01, however, the company has experienced a -3.86% decrease in its stock price over the last five trading days. Zacks Investment Research reported 2024-05-01 that Here is a sneak peek into how the five MedTech stocks, HOLX, ZBH, ILMN, TFX and BRKR, are expected to fare in their quarterly results slated to be released tomorrow.
BRKR’s Market Performance
BRKR’s stock has fallen by -3.86% in the past week, with a monthly drop of -13.07% and a quarterly rise of 10.52%. The volatility ratio for the week is 2.43% while the volatility levels for the last 30 days are 2.69% for Bruker Corp. The simple moving average for the past 20 days is -6.49% for BRKR’s stock, with a 9.83% simple moving average for the past 200 days.
Analysts’ Opinion of BRKR
Many brokerage firms have already submitted their reports for BRKR stocks, with JP Morgan repeating the rating for BRKR by listing it as a “Overweight.” The predicted price for BRKR in the upcoming period, according to JP Morgan is $90 based on the research report published on February 14, 2024 of the current year 2024.
Wells Fargo, on the other hand, stated in their research note that they expect to see BRKR reach a price target of $72. The rating they have provided for BRKR stocks is “Equal Weight” according to the report published on December 19th, 2023.
Wolfe Research gave a rating of “Outperform” to BRKR, setting the target price at $80 in the report published on December 13th of the previous year.
BRKR Trading at -9.94% from the 50-Day Moving Average
After a stumble in the market that brought BRKR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -16.69% of loss for the given period.
Volatility was left at 2.69%, however, over the last 30 days, the volatility rate increased by 2.43%, as shares sank -13.15% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -2.55% lower at present.
During the last 5 trading sessions, BRKR fell by -3.86%, which changed the moving average for the period of 200-days by +7.55% in comparison to the 20-day moving average, which settled at $83.92. In addition, Bruker Corp saw 7.55% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BRKR starting from Requardt Hermann Fritz, who sale 15,000 shares at the price of $90.06 back on Mar 04 ’24. After this action, Requardt Hermann Fritz now owns 23,147 shares of Bruker Corp, valued at $1,350,898 using the latest closing price.
Busse Falko, the PRESIDENT, BIOSPIN GROUP of Bruker Corp, sale 28,122 shares at $85.48 during a trade that took place back on Feb 28 ’24, which means that Busse Falko is holding 32,859 shares at $2,403,890 based on the most recent closing price.
Stock Fundamentals for BRKR
Current profitability levels for the company are sitting at:
- 0.15 for the present operating margin
- 0.51 for the gross margin
The net margin for Bruker Corp stands at 0.14. The total capital return value is set at 0.14. Equity return is now at value 34.30, with 10.87 for asset returns.
Based on Bruker Corp (BRKR), the company’s capital structure generated 0.48 points at debt to capital in total, while cash flow to debt ratio is standing at 0.27. The debt to equity ratio resting at 0.94. The interest coverage ratio of the stock is -11.98.
Currently, EBITDA for the company is 597.2 million with net debt to EBITDA at 1.55. When we switch over and look at the enterprise to sales, we see a ratio of 3.97. The receivables turnover for the company is 4.77for trailing twelve months and the total asset turnover is 0.7. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.80.
Conclusion
To sum up, Bruker Corp (BRKR) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
